BetaNews: Ancestry. com announces COVID-19 (coronavirus) testing

BetaNews: Ancestry.com announces COVID-19 (coronavirus) testing. “With the current pandemic continuing to grow in some areas, and unemployment rising even faster than food prices, we need problem solvers. Help at this time comes mostly from doctors and scientists, but can also come from other surprising areas. If you’ve recently taken an AncestryDNA test, Ancestry.com is inviting you to supply some information that could assist in the fight against COVID-19.”

Hartford Courant: Most New York coronavirus cases came from Europe, genomes show

Hartford Courant: Most New York coronavirus cases came from Europe, genomes show. “New research indicates that the coronavirus began to circulate in the New York area by mid-February, weeks before the first confirmed case, and that travelers brought in the virus mainly from Europe, not Asia. ‘The majority is clearly European,’ said Harm van Bakel, a geneticist at Icahn School of Medicine at Mount Sinai, who co-wrote a study awaiting peer review.”

South China Morning Post: Researchers target bat genes in quest for drug to combat Covid-19

South China Morning Post: Researchers target bat genes in quest for drug to combat Covid-19. “A multinational research team has identified a gene inhibitor in bats that could have potential in the search for antiviral drugs to treat the pandemic disease Covid-19. In a research paper published online on Monday, scientists from China, Singapore and the United States said carolacton, which inhibits a specific bat gene, could help suppress the infection of Sars-CoV-2, the coronavirus that causes Covid-19.”

Phys .org: How to quickly and efficiently identify huge gene data sets to help coronavirus research

Phys .org: How to quickly and efficiently identify huge gene data sets to help coronavirus research. “Thanks to the advancement of sequencing technology, it’s possible to produce massive amounts of genome sequence data on various species. It’s crucial to examine pan-genomic data—the entire set of genes possessed by all members of a particular species—particularly in areas like bacteria and virus research, investigation of drug resistance mechanisms and vaccine development. For example, why is the coronavirus resistant to common drugs? Can big data help to rapidly identify the characteristics of such novel virus strains? A group of researchers supported by the EU-funded PANGAIA project is now tackling this challenge by developing methods for comparing gigantic gene data sets.”

News-Medical Net: CRG launches new database to advance international research efforts on COVID-19

News-Medical Net: CRG launches new database to advance international research efforts on COVID-19. “Researchers from the Centre for Genomic Regulation (CRG) have launched a new database to advance the international research efforts studying COVID-19. The publicly-available, free-to-use resource (https://covid.crg.eu) can be used by researchers from around the world to study how different variations of the virus grow, mutate and make proteins.”

BetaKit: DNAstack Launches New Tool To Help Scientists Share Genomic Data On Covid-19

BetaKit: DNAstack Launches New Tool To Help Scientists Share Genomic Data On Covid-19. “DNAstack has launched a new tool for scientific and medical communities to share and discover knowledge about the genetics of COVID-19 (coronavirus). The tool, which is being called the COVID-19 Beacon, is available on DNAstack’s website.”

Policy Options: Indigenous DNA database should be managed by its people

Policy Options: Indigenous DNA database should be managed by its people. “There is no denying the value of DNA as an investigational tool. However, that value should be considered in the context of the relationship between Indigenous people and the Canadian government. Given the tenuous past and present relationship between Canada’s Indigenous population and the Canadian state, who controls the ‘genetic identifiers’ of Indigenous people and for what purpose should raise questions. It is time for Indigenous people to have greater control over their genetic information and how it is used.”